Abnormal Uterine Bleeding

Key Points

  • Abnormal uterine bleeding (AUB) includes heavy, prolonged, irregular, postcoital, and postmenopausal bleeding patterns.
  • Heavy bleeding can cause iron-deficiency anemia with fatigue, dyspnea, and reduced quality of life.
  • Differential diagnosis is broad and includes anovulatory dysfunction, hormonal disorders, structural uterine pathology, pregnancy-related causes, infection, medication effects, and malignancy.
  • Initial evaluation prioritizes bleeding severity, pregnancy exclusion, anemia risk, and cause-focused diagnostic testing.
  • Management commonly combines medical therapy (NSAIDs, iron, hormonal options) and selected procedural/surgical pathways when bleeding remains uncontrolled.

Pathophysiology

AUB reflects disruption of normal endometrial shedding and hemostasis. In anovulatory states, prolonged unopposed estrogen can lead to excessive endometrial buildup followed by unpredictable or heavy shedding. Structural causes such as fibroids or polyps can increase endometrial surface disruption and bleeding burden.

Medication effects (for example anticoagulants) and coagulation disorders can worsen bleeding tendency. Pregnancy-related causes and gynecologic malignancy must be excluded promptly when risk factors or red-flag bleeding patterns are present.

Classification

  • Menorrhagia/heavy menstrual bleeding: Excessive flow, including large clots or prolonged menses.
  • Hypermenorrhea: Menstrual bleeding that lasts longer than expected.
  • Metrorrhagia: Irregular bleeding between expected cycles.
  • Menometrorrhagia: Heavy and irregular bleeding pattern combined.
  • Postcoital bleeding: Bleeding after intercourse.
  • Postmenopausal bleeding: Any uterine bleeding after menopause and requires prompt evaluation.

Nursing Assessment

NCLEX Focus

Prioritize hemodynamic risk, pregnancy exclusion, and red flags for malignancy or severe anemia before nonurgent symptom management.

  • Quantify bleeding burden: pad/tampon saturation frequency, clot size, total duration, and nighttime changes.
  • Screen for high-risk heavy-bleeding cues (for example saturation of one or more pad/tampon per hour for several consecutive hours, quarter-sized clots or larger, and bleeding longer than about 7 days).
  • Assess symptom impact: fatigue, dizziness, shortness of breath, palpitations, activity intolerance, and quality-of-life disruption.
  • Obtain focused menstrual and reproductive history: age at menarche, cycle interval, usual duration, heavy-flow days, and pattern changes.
  • Assess for associated causes/risk factors: anovulation, PCOS, fibroids, polyps, endometriosis, bleeding disorders, anticoagulant use, IUD context, PID symptoms, pregnancy loss concern, and malignancy cues.
  • Trend objective status and diagnostics as ordered: CBC for anemia, thyroid studies, coagulation panel, pregnancy test, and cervical/endometrial evaluation.
  • Prepare for and support diagnostic procedures when ordered (transvaginal ultrasound, sonohysterogram, hysteroscopy, or endometrial biopsy).

Nursing Interventions

  • Escalate acute instability or severe ongoing blood loss promptly and coordinate urgent gynecologic evaluation.
  • Support cause-focused workup while providing symptom-relief measures and anemia monitoring.
  • Administer and monitor prescribed therapies: NSAIDs, iron supplementation, and hormonal regimens according to risk profile.
  • Reinforce medication safety: avoid NSAID self-escalation in clients on anticoagulants or with known bleeding disorders unless provider-directed.
  • Teach cycle/symptom tracking (calendar or app) to improve treatment adjustment and follow-up decisions.
  • Counsel on supportive lifestyle measures (balanced diet, regular activity as tolerated, stress-reduction strategies).
  • Prepare clients for procedural/surgical pathways when medical therapy is inadequate (for example myomectomy, uterine artery embolization, endometrial ablation, or hysterectomy).
  • Align treatment counseling with fertility goals, especially when discussing endometrial ablation or definitive surgery.

Postmenopausal Bleeding Rule

Any postmenopausal uterine bleeding requires prompt diagnostic evaluation for endometrial pathology or malignancy.

Pharmacology

Drug ClassExamplesKey Nursing Considerations
nsaidsIbuprofen, naproxenCan reduce menstrual blood loss via prostaglandin suppression; monitor GI/bleeding risk and avoid unsupervised use with anticoagulants.
iron replacementOral iron supplementsTreat iron-deficiency anemia from chronic blood loss; monitor tolerance and hemoglobin trend.
hormonal-therapyEstrogen/progestin regimensRegulates cycles and reduces bleeding in selected clients; review thrombosis and cancer-risk contraindications.
levonorgestrel-intrauterine-systemHormone-infused IUD optionsReduces heavy menstrual bleeding in selected clients and can provide concurrent contraception.

Clinical Judgment Application

Clinical Scenario

A reproductive-age client reports bleeding for 9 days with quarter-sized clots, hourly pad saturation, fatigue, and new shortness of breath on exertion.

  • Recognize Cues: Heavy prolonged bleeding with anemia symptoms.
  • Analyze Cues: Pattern is consistent with high-burden AUB and possible iron-deficiency progression.
  • Prioritize Hypotheses: Immediate priority is bleeding severity and oxygen-delivery risk, with pregnancy and structural/malignant causes excluded promptly.
  • Generate Solutions: Coordinate urgent labs and gynecologic evaluation while implementing ordered symptom-control therapy.
  • Take Action: Trend bleeding and cardiopulmonary status, reinforce medication and return-precaution teaching.
  • Evaluate Outcomes: Bleeding burden decreases, anemia stabilizes/improves, and cause-directed treatment plan is established.

Self-Check

  1. Which bleeding-pattern findings should trigger urgent rather than routine follow-up?
  2. Why is pregnancy testing part of standard AUB evaluation?
  3. How do fertility goals change counseling around ablation versus hysterectomy?